COMMUNIQUÉS West-GlobeNewswire

Life Biosciences to Present First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies at Eyecelerator 2026
01/10/2026
BOSTON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a biotechnology company pioneering cellular rejuvenation medicines to reverse diseases of aging, today announced that the company will present new [...]
HealthLynked Selects DRCARE247 as Telemedicine Partner to Expand Integrated Virtual Care Platform
01/10/2026
NAPLES, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK ), a healthcare technology company focused on AI-powered patient engagement, care coordination, and provider connectivity, today [...]
Alignment Health Expands Access to Personalized Senior Care in 2027 with New Markets, Provider Networks and Medicare Advantage Plan Options
01/10/2026
Alignment Health expands into San Antonio, Charlotte and California's Central Valley, bringing its high-tech, high-touch care model to nearly 9.5 million Medicare-eligible seniors across five states ORANGE, Calif., Oct [...]
Balt Announces First Patients Enrolled in Silk Vista Baby™ PIONEER Study
01/10/2026
IRVINE, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Balt announced today it has enrolled the first patients in North America in the premarket approval (PMA) clinical trial, PIONEER ( PI votal Study O f the Silk Vista Baby [...]
Taysha Gene Therapies Announces Multiple Encore Presentations Supporting TSHA-102 Rett Syndrome Clinical Program at the 55th Child Neurology Society Annual Meeting
01/10/2026
DALLAS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]
Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy
01/10/2026
330 patients randomized as of September 30, 2026, surpassing full trial enrollment target Company reiterates prior guidance: primary endpoint data to be submitted for late-breaking presentation consideration at a major [...]
Clover Health’s 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member Value
01/10/2026
Clover’s portfolio combines high-choice PPO access and meaningful member benefits with a Clover Assistant-powered care model WILMINGTON, Del., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: [...]
Teal Lights and Shared Stories: The Facial Pain Association Marks Facial Pain Awareness Month This October
01/10/2026
Landmarks worldwide will glow teal in solidarity. The month also features patient stories, educational resources, and ways for everyone to get involved SUWANEE, Ga., Oct. 01, 2026 (GLOBE NEWSWIRE) -- October is Facial [...]
Stryker to announce third quarter 2026 financial results
01/10/2026
Portage, Michigan, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, October 29, 2026, to discuss its third quarter 2026 financial results. The live [...]
Daxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026
01/10/2026
FDA 510(k)-cleared next-generation diagnostic platform delivers 3x faster results with 50% less blood, setting a new standard for data-driven heart failure management. Key Highlights: Commercial Acceleration: Daxor to [...]
Allogenetics Appoints Dr. Olaf Schermeier as Chairman of the Advisory Board
01/10/2026
Hanover, Germany, October 01, 2026 – Allogenetics today announced the appointment of Olaf Schermeier, PhD, as Chairman of its Advisory Board. Dr. Schermeier brings more than 25 years of industry experience, including [...]
Atrogi announces positive human data for ATR-258, its first-in-class, oral therapy designed to improve muscle function and body composition
01/10/2026
In the 8-week study, ATR-258 was well-tolerated and associated with an approximately 13% mean improvement in lower extremity muscle power in combination with a beneficial effect on body composition, with an increase in [...]
Numab Therapeutics Appoints Dr. Rajesh Chopra as Chief Scientific Officer to Advance its Proprietary Multispecific Antibody Pipeline
01/10/2026
Appointment brings extensive experience spanning drug discovery, translational medicine, clinical development and scientific leadership HORGEN, Switzerland, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Numab Therapeutics (“Numab [...]
DaltonTx, the decision engine for drug discovery, launches advanced AI-powered antibody discovery platform
01/10/2026
New capabilities enable researchers to analyse, characterise and prioritise antibody candidates at scale Integrated AI models and workflows support better informed decisions about which antibodies to progress [...]
Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes
01/10/2026
In the SYNCHRONIZE-2 trial, which met its co-primary endpoints, participants achieved significant body weight reduction of up to 13.1% versus 3.1% in the placebo arm, after 76 weeks of treatment with survodutide in [...]
Zealand Pharma announces Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes
01/10/2026
Company announcement – No. 52 / 2026 Zealand Pharma announces Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people [...]
SkinHealth Systems Expands SkinStylus® SteriLock® MicroSystem to Europe
01/10/2026
Professional microneedling and nano-needling device launches in UK, Ireland, Germany, France, Spain and Portugal LONG BEACH, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems (Nasdaq: SKIN), home to flagship [...]
Le SkinStylus® SteriLock MicroSystem de SkinHealth Systems désormais disponible sur le marché européen
01/10/2026
Le dispositif professionnel de microneedling et de nanoneedling fait son entrée au Royaume-Uni, en Irlande, en Allemagne, en France, en Espagne et au Portugal LONG BEACH, Californie, 01 oct. 2026 (GLOBE NEWSWIRE) -- [...]
Oculis Joins the National Multiple Sclerosis Society’s Campaign to End MS
01/10/2026
Oculis and the National Multiple Sclerosis Society’s campaign share a common goal to accelerate breakthroughs in MS research and improve patients’ quality of life ZUG, Switzerland, October 1, 2026 -- Oculis Holding AG ( [...]

Pages